Morgan Stanley’s stock has reached a historic all-time high of $145.17, marking an impressive annual increase of approximately 43 percent. With a market capitalization of $233 billion and a price-to-earnings ratio of 16.2, the stock still appears reasonably valued despite its strong performance. The financial giant reported mixed signals in its Q2 2025 quarterly results, with earnings per share rising to $2.13—representing a 17 percent year-over-year increase but an 18 percent decrease compared to the previous quarter. Nevertheless, these results exceeded analyst estimates by 7.5 percent. The company’s solid dividend policy has also been noteworthy, with an attractive yield of 2.8 percent and eleven consecutive years of dividend increases, underscoring the firm’s financial stability.
Divergent Analyst Perspectives
Analysts remain divided on Morgan Stanley’s outlook. Evercore ISI raised its price target from $146 to $150 per share, praising the strong performance in wealth management and investment management divisions. In contrast, Freedom Broker downgraded the stock from "Buy" to "Hold," maintaining a price target of $126 per share. In a strategic personnel decision, the investment bank appointed Ashish Kumbhat, formerly of Bank of America, to co-lead its banking advisory group alongside Elizabeth Jacobs—a move highlighting the firm’s ambitions in the lucrative consulting business.
